Profil
Li Deng-Ke served as President, CEO, CFO, Director & CAO at Rich Pharmaceuticals, Inc. from 2012 to 2013.
Prior to that, he worked as a Technician at KTV Ltd.
Mr. Deng-Ke received his undergraduate degree from Sichuan Normal University in 2006.
Anciens postes connus de Li Deng-Ke
| Sociétés | Poste | Fin |
|---|---|---|
| RICH PHARMACEUTICALS, INC. | Directeur Financier/CFO | 29/03/2013 |
| KTV Ltd. | Corporate Officer/Principal | - |
Formation de Li Deng-Ke
| Sichuan Normal University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Rich Pharmaceuticals, Inc.
 Rich Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rich Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages on developing innovative therapies in oncology. It develops RP-323 for the treatment of Hodgkin’s lymphoma, Acute Myelogenous Leukemia, and to cause elevation of white blood cells in patients depleted of these elements due to various conditions. The company was founded on August 9, 2010 and is headquartered in Beverly Hills, CA. | Health Technology |
| KTV Ltd. |
